200 related articles for article (PubMed ID: 31795352)
41. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and pharmacokinetic characterization of a pH-sensitive polyethylene glycol ginsenoside CK (PEG-CK) conjugate.
Mathiyalagan R; Subramaniyam S; Kim YJ; Natarajan S; Min JW; Kim SY; Yang DC
Biosci Biotechnol Biochem; 2014; 78(3):466-8. PubMed ID: 25036835
[TBL] [Abstract][Full Text] [Related]
43. Ginsenoside Rh1 ameliorates high fat diet-induced obesity in mice by inhibiting adipocyte differentiation.
Gu W; Kim KA; Kim DH
Biol Pharm Bull; 2013; 36(1):102-7. PubMed ID: 23302642
[TBL] [Abstract][Full Text] [Related]
44. Production of the Rare Ginsenoside Rh2-MIX (20(
Song BK; Kim KM; Choi KD; Im WT
J Microbiol Biotechnol; 2017 Jul; 27(7):1233-1241. PubMed ID: 28478658
[TBL] [Abstract][Full Text] [Related]
45. Poly(ethylene glycol) modification of beta-glucuronidase-antibody conjugates for solid-tumor therapy by targeted activation of glucuronide prodrugs.
Cheng TL; Chen BM; Chan LY; Wu PY; Chern JW; Roffler SR
Cancer Immunol Immunother; 1997 Aug; 44(6):305-15. PubMed ID: 9298932
[TBL] [Abstract][Full Text] [Related]
46. Increased antitumor efficacy of ginsenoside Rh
Xia X; Tao J; Ji Z; Long C; Hu Y; Zhao Z
Drug Deliv; 2020 Dec; 27(1):1369-1377. PubMed ID: 32998576
[TBL] [Abstract][Full Text] [Related]
47. Stereospecificity of hydroxyl group at C-20 in antiproliferative action of ginsenoside Rh2 on prostate cancer cells.
Liu J; Shimizu K; Yu H; Zhang C; Jin F; Kondo R
Fitoterapia; 2010 Oct; 81(7):902-5. PubMed ID: 20554003
[TBL] [Abstract][Full Text] [Related]
48. pH sensitive nano layered double hydroxides reduce the hematotoxicity and enhance the anticancer efficacy of etoposide on non-small cell lung cancer.
Zhu R; Wang Q; Zhu Y; Wang Z; Zhang H; Wu B; Wu X; Wang S
Acta Biomater; 2016 Jan; 29():320-332. PubMed ID: 26485164
[TBL] [Abstract][Full Text] [Related]
49. PEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinoma.
Luo T; Loira-Pastoriza C; Patil HP; Ucakar B; Muccioli GG; Bosquillon C; Vanbever R
J Control Release; 2016 Oct; 239():62-71. PubMed ID: 27515664
[TBL] [Abstract][Full Text] [Related]
50. Ginsenoside Rh2 reverses cyclophosphamide-induced immune deficiency by regulating fatty acid metabolism.
Qian Y; Huang R; Li S; Xie R; Qian B; Zhang Z; Li L; Wang B; Tian C; Yang J; Xiang M
J Leukoc Biol; 2019 Nov; 106(5):1089-1100. PubMed ID: 31211478
[TBL] [Abstract][Full Text] [Related]
51. Characterizing the mechanism for ginsenoside-induced cytotoxicity in cultured leukemia (THP-1) cells.
Kitts DD; Popovich DG; Hu C
Can J Physiol Pharmacol; 2007 Nov; 85(11):1173-83. PubMed ID: 18066119
[TBL] [Abstract][Full Text] [Related]
52. Development of superparamagnetic iron oxide nanoparticles via direct conjugation with ginsenosides and its in-vitro study.
Singh H; Du J; Singh P; Mavlonov GT; Yi TH
J Photochem Photobiol B; 2018 Aug; 185():100-110. PubMed ID: 29885646
[TBL] [Abstract][Full Text] [Related]
53. PEGylated nanostructured lipid carriers loaded with 10-hydroxycamptothecin: an efficient carrier with enhanced anti-tumour effects against lung cancer.
Zhang X; Gan Y; Gan L; Nie S; Pan W
J Pharm Pharmacol; 2008 Aug; 60(8):1077-87. PubMed ID: 18644200
[TBL] [Abstract][Full Text] [Related]
54. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis.
Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y
Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384
[TBL] [Abstract][Full Text] [Related]
55.
Dhande R; Tyagi A; Sharma RK; Thakkar H
Pulm Pharmacol Ther; 2018 Apr; 49():36-45. PubMed ID: 29337265
[TBL] [Abstract][Full Text] [Related]
56. Anti-Inflammatory Effect of Ginsenoside Rh
Baatar D; Siddiqi MZ; Im WT; Ul Khaliq N; Hwang SG
J Med Food; 2018 Oct; 21(10):951-960. PubMed ID: 30239266
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and properties of magnetic nanotheranostics coated with polyethylene glycol/5-fluorouracil/layered double hydroxide.
Ebadi M; Saifullah B; Buskaran K; Hussein MZ; Fakurazi S
Int J Nanomedicine; 2019; 14():6661-6678. PubMed ID: 31695362
[TBL] [Abstract][Full Text] [Related]
58. Ginsenoside Rh1 eliminates the cytoprotective phenotype of human immunodeficiency virus type 1-transduced human macrophages by inhibiting the phosphorylation of pyruvate dehydrogenase lipoamide kinase isozyme 1.
Jeong JJ; Kim B; Kim DH
Biol Pharm Bull; 2013; 36(7):1088-94. PubMed ID: 23811558
[TBL] [Abstract][Full Text] [Related]
59. Co-treatment with ginsenoside Rh2 and betulinic acid synergistically induces apoptosis in human cancer cells in association with enhanced capsase-8 activation, bax translocation, and cytochrome c release.
Li Q; Li Y; Wang X; Fang X; He K; Guo X; Zhan Z; Sun C; Jin YH
Mol Carcinog; 2011 Oct; 50(10):760-9. PubMed ID: 21751259
[TBL] [Abstract][Full Text] [Related]
60. RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumor-targeting capability.
Huang ZG; Lv FM; Wang J; Cao SJ; Liu ZP; Liu Y; Lu WY
Int J Pharm; 2019 Feb; 556():217-225. PubMed ID: 30557679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
